Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;30:830-836

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thorin, E.
Right arrow Articles by Bevan, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thorin, E.
Right arrow Articles by Bevan, J. A.

(Hypertension. 1997;30:830-836.)
© 1997 American Heart Association, Inc.


Articles

Reversal of Endothelin-1 Release by Stimulation of Endothelial {alpha}2-Adrenoceptor Contributes to Cerebral Vasorelaxation

Eric Thorin; S. Martin Shreeve; Nathalie Thorin-Trescases; ; John A. Bevan

From The Totman Laboratory for Human Cerebrovascular Research, Department of Pharmacology, Given Building, University of Vermont (Burlington).

Abstract Agonists acting on the vascular endothelium can modulate the release of a number of factors that interact with the surrounding smooth muscle cells and influence their tone. One such factor is the vasoconstricting agent endothelin-1 (ET-1), which has been implicated in several disease states, including stroke. However, very little is known about the physiological role of ET-1 in the cerebral circulation. We demonstrate that activation of {alpha}2-adrenoceptors in human pial artery endothelial cells reduces both constitutive and agonist-stimulated release of immunoreactive ET-1. That this has physiological relevance is supported by our demonstration that in segments of rabbit middle cerebral arteries, {alpha}2-adrenoceptor activation reduces the release of endothelium-derived ET-1 and causes an endothelium-dependent relaxation. The adrenoceptor-dependent relaxation was not blocked by combined addition of indomethacin and N{omega}-nitro-L-arginine in 25 mmol/L KCl-depolarizing physiological solution but was selectively antagonized by a subthreshold concentration of exogenous ET-1. Our data suggest that activation of endothelial {alpha}2-adrenoceptor would favor a decrease in ET-1 production and possibly promote vascular relaxation.


Key Words: endothelium • artery, cerebral • receptors, adrenergic • endothelin-1 • human • rabbits




This article has been cited by other articles:


Home page
HypertensionHome page
L. Luksha, L. Poston, J.-A. Gustafsson, L. Aghajanova, and K. Kublickiene
Gender-Specific Alteration of Adrenergic Responses in Small Femoral Arteries From Estrogen Receptor-{beta} Knockout Mice
Hypertension, November 1, 2005; 46(5): 1163 - 1168.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. J. FitzGerald, B. A. Murray, and D. J. Walsh
Hypotensive Peptides from Milk Proteins
J. Nutr., April 1, 2004; 134(4): 980S - 988S.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
H. Iida, M. Iida, H. Ohata, K. Nagase, and S. Dohi
Hypothermia Attenuates the Vasodilator Effects of Dexmedetomidine on Pial Vessels in Rabbits In Vivo
Anesth. Analg., February 1, 2004; 98(2): 477 - 482.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. Guimaraes and D. Moura
Vascular Adrenoceptors: An Update
Pharmacol. Rev., June 1, 2001; 53(2): 319 - 356.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Baumgart, C. Naber, M. Haude, O. Oldenburg, R. Erbel, G. Heusch, and W. Siffert
G Protein {beta}3 Subunit 825T Allele and Enhanced Coronary Vasoconstriction on {alpha}2-Adrenoceptor Activation
Circ. Res., November 12, 1999; 85(10): 965 - 969.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. Thorin, R. Parent, Z. Ming, and M. Lavallee
Contribution of endogenous endothelin to large epicardial coronary artery tone in dogs and humans
Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H524 - H532.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. Thorin, P. L. Huang, M. C. Fishman, and J. A. Bevan
Nitric Oxide Inhibits {alpha}2-Adrenoceptor–Mediated Endothelium-Dependent Vasodilation
Circ. Res., June 29, 1998; 82(12): 1323 - 1329.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Thorin, P. Cernacek, and J. Dupuis
Endothelin-1 Regulates Tone of Isolated Small Arteries in the Rat : Effect of Hyperendothelinemia
Hypertension, April 1, 1998; 31(4): 1035 - 1041.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
E. Thorin, T.-D. Nguyen, A. Bouthillier, and F. M. Faraci
Control of Vascular Tone by Endogenous Endothelin-1 in Human Pial Arteries • Editorial Comment
Stroke, January 1, 1998; 29(1): 175 - 180.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Vequaud and E. Thorin
Endothelial G Protein {beta}-Subunits Trigger Nitric Oxide- but not Endothelium-Derived Hyperpolarizing Factor-Dependent Dilation in Rabbit Resistance Arteries
Circ. Res., October 12, 2001; 89(8): 716 - 722.
[Abstract] [Full Text] [PDF]